PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2018.10062018243299-301Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?Yong Kyun Chohttp://e-cmh.org/upload/pdf/cmh-2018-1006.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2018.1006, http://e-cmh.org/upload/pdf/cmh-2018-1006.pdf
Clinical and Molecular Hepatology10.3350/cmh.2018.00062018243331-338Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver diseaseSaba Sayari, Hassan Neishaboori, Maryam Jameshoranihttp://e-cmh.org/upload/pdf/cmh-2018-0006.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2018.0006, http://e-cmh.org/upload/pdf/cmh-2018-0006.pdf
Hepatology International10.1007/s12072-015-9625-1201594481-483Two are better than one: noninvasive assessment of liver fibrosis in nonalcoholic fatty liver diseaseGrace Lai-Hung Wong, Henry Lik-Yuen Chanhttp://link.springer.com/content/pdf/10.1007/s12072-015-9625-1.pdf, http://link.springer.com/article/10.1007/s12072-015-9625-1/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12072-015-9625-1
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loombahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.65
Alimentary Pharmacology & Therapeutics10.1111/j.1365-2036.2007.03246.x2007258883-889GI Epidemiology: nonalcoholic fatty liver diseaseP. ANGULOhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2007.03246.x
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Mollestonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.66
Clinical Liver Disease10.1002/cld.75201214125-128Pediatric nonalcoholic fatty liver disease: Prevalence, diagnosis, risk factors, and managementStavra A. Xanthakos, Rohit Kohlihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.75
Clinical Liver Disease10.1002/cld.27201214112-113Natural history of nonalcoholic fatty liver diseaseRohini Mehta, Zobair M. Younossihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.27
Diagnosis of Liver Disease10.1007/978-981-13-6806-6_7201975-84Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease/Nonalcoholic SteatohepatitisEtsuko Hashimoto, Masaki Iwai, Arief A. Suriawinatahttp://link.springer.com/content/pdf/10.1007/978-981-13-6806-6_7
Talanta10.1016/j.talanta.2011.04.0512011851673-680Liquid chromatographic determination of sitagliptin either alone or in ternary mixture with metformin and sitagliptin degradation productRamzia I. El-Bagary, Ehab F. Elkady, Bassam M. Ayoubhttps://api.elsevier.com/content/article/PII:S0039914011003808?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0039914011003808?httpAccept=text/plain